News
Pfizer PFE announced that it is discontinuing the development of danuglipron, its investigational oral GLP-1 receptor agonist (GLP-1 RA), which is being developed to treat obesity. The decision ...
The study was published in the journal Nature. Paradoxically, anecdotal evidence suggests that people with obesity may take less pleasure in eating than those of normal weight. Brain scans of ...
A new UK weather forecast suggests that snow could fall in England, Scotland and Wales on Saturday, April 5. Weather maps from WXCHARTS, using Metdesk data, show wintry showers falling ...
Struggling with excess weight? Blame mom. Over one billion people worldwide are living with obesity, defined as having a BMI of 30 or higher. The World Health Organization officially declared ...
On March 10, 2025, Superior Court Judge Benjamin Hanna ordered former Shasta County Supervisor Patrick Jones to prepare a “legally adequate” Environmental Impact Report (EIR) on his proposed ...
Britons are poised for snow as the latest weather maps show parts of England and Scotland affected just days after wall to wall sunshine. One map generated today (Sunday, April 13) shows snow over ...
Obesity prevention strategies often focus on diet, but eating behaviors also play a key role. In a recent study, researchers from Japan investigated factors influencing meal duration, including ...
SAN DIEGO (KGTV) – The Office of the State Fire Marshal released new maps that indicate which parts of San Diego County are in a very high-risk zone for fires. For the first time in 15 years ...
Heavy snow is set to hit Scotland this week ... wintry conditions have been picked up on an advanced weather modelling map, the Mirror reports. In other parts of the UK, the model has predicted ...
San Diego County saw a nearly 9% decrease in acreage with “very high” fire hazard compared to 2011, Cal Fire reported this week in a release of new maps for areas under local and county fire ...
March 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O), opens new tab experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results